A non-enzymatic derived arachidonyl peroxide, 8-iso-prostaglandin F 2α, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm

Neuroscience Letters

Volumn 373, Issue 3, 2005, Pages 222-225

  Asaeda, Masahiro ^a   Sakamoto, Makoto ^a   Kurosaki, Masamichi ^a   Tabuchi, Sadaharu ^a   Kamitani, Hideki ^a   Yokota, Masayuki ^a   Watanabe, Takashi ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

8 Iso prostaglandin F2 ; Cerebrospinal fluid; Delayed cerebral vasospasm; Lipid peroxides; Subarachnoid hemorrhage

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; LIPID PEROXIDE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ARACHIDONIC ACID DERIVATIVE; DRUG DERIVATIVE; PEROXIDE; PROSTAGLANDIN F2 ALPHA;

ADULT; AGED; ARTICLE; BIOLOGICAL ACTIVITY; BRAIN INFARCTION; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOVASCULAR SURGERY; FEMALE; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION; COMPARATIVE STUDY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ARACHIDONIC ACIDS; DINOPROST; FEMALE; HUMANS; MALE; MIDDLE AGED; PEROXIDES; STATISTICS, NONPARAMETRIC; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 16644377315     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.10.008     Document Type: Article

References (24)

1. C.M. Fisher, J.P. Kistler, J.M. Davis, Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning, Neurosurgery 6 (1980) 1-9.
2. E.J. Goetzl, Oxygenation products of arachidonic acid as mediators of hypersensitivity and inflammation, Med. Clin. North Am. 65 (1981) 809-828.
3. A. Greco, L. Minghetti, G. Levi, Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases, Neurochem. Res. 25 (2000) 1357-1364.
4. A. Greco, L. Minghetti, G. Sette, C. Fieschi, G. Levi, Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis, Neurology 53 (1999) 1876-1979.
5. S.W. Hoffman, S. Moore, E.F. Ellis, Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles, Stroke 28 (1997) 844-849.
6. S.W. Hoffman, B.A. Rzigalinski, K.A. Willoughby, E.F. Ellis, Astrocytes generate isoprostanes in response to trauma or oxygen radicaols, J. Neurotrauma 17 (2000) 415-420.
7. J.G. Marin, S. Cornet, B. Spinnewyn, C. Demerle-Pallardy, M. Auguet, P.E. Chabrier, BN 80933 inhibits p2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures, NeuroReport 11 (2000) 1357-1360.
8. W.F. Matthews, W.B. Frommeyer Jr., The in vitro behavior of erythrocytes in human cerebrospinal fluid, J. Lab. Clin. Med. 45 (1955) 508-515.
9. J.D. Morrow, J.A. Awad, H.J. Boss, I.A. Blair, L.J. Roberts II, Non-cyclooxygenase-derived prostanoids (p2-isoprostanes) are formed in situ on phospholipids, Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10721-10725.
10. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 9383-9387.
11. J.D. Morrow, L.J. Roberts II, The isoprostanes-current knowledge and directions for future research, Biochem. Pharmacol. 51 (1996) 1-9.
12. D.H. Nugteren, The determination of prostaglandin metabolites in human urine, J. Biol. Chem. 250 (1975) 2808-2812.
13. H. Okamoto, M. Tanabe, M. Iwatsuki, M. Nishiyama, K. Akatsuka, T. Watanabe, T. Hori, E. Nakajima, Role of 12-HPETE in the pathogenesis of cerebral vasospasm, Adv. Exp. Med. Biol. 407 (1997) 21-25.
14. 2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo, FASEB J. 12 (1998) 1777-1783.
15. I. Saito, Y. Ueda, K. Sano, Significance of vasospasm in the treatment of ruptured intracranial aneurysm, J. Neurosurg. 47 (1977) 412-429.
16. 2α, participates in the pathogenesis of delayed cerebral vasospasm in a canine SAH model, Neurol. Res. 24 (2002) 301-306.
17. B. Samuelsson, Leukotrienes: mediators of immediate hypersensitivity reaction and inflammation, Science 220 (1983) 568-575.
18. T. Sasaki, T. Asano, K. Takakura, K. Sano, T. Nakamura, N. Suzuki, S. Imabayashi, Y. Ishikawa, Cerebral vasospasm and lipid peroxidation-lipid peroxides in the cerebrospinal fluid after subarachnoid hemorrhage, Brain Nerve 34 (1982) 1191-1196.
19. T. Sasaki, S. Wakai, T. Asano, T. Watanabe, T. Kirino, K. Sano, The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery-an experimental study on cerebral vasospasm, J. Neurosurg. 54 (1981) 357-365.
20. T. Shimizu, T. Watanabe, T. Asano, Y. Seyama, K. Takakura, Activation of the arachidonate 5-lipoxygenase pathway in the canine basilar artery after experimental subarachnoid hemorrhage, J. Neurochem. 51 (1988) 1126-1131.
21. T. Watanabe, T. Asano, T. Shimizu, Arachidonic acid lipoxygenase products participate in the pathogenesis of delayed cerebral ischemia, in: G.B. Nicolas, B. Pierre, D.G. Myron (Eds.), Neurochemical Correlates of Cerebral Ischemia, Advances in Neurochemistry, vol. 7, Plenum Press, New York, 1992, pp. 139-159.
22. T. Watanabe, T. Asano, T. Shimizu, Y. Seyama, K. Takakura, Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm, J. Neurochem. 50 (1988) 1145-1150.
23. T. Watanabe, T. Sakaki, T. Asano, K. Takakura, K. Sano, T. Fuchinoue, K. Watanabe, S. Yoshimura, K. Abe, Changes in glutathione peroxidase and lipid peroxides in cerebrospinal fluid and serum after subarachnoid hemorrhage-with special reference to the occurrence of cerebral vasospasm, Neurol. Med. Chir. (Tokyo) 28 (1988) 645-649.
24. M. Yokota, E. Tani, Y. Maeda, K. Kokubu, Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm, Stroke 18 (1987) 512-518.